-
41
Cognitive dysfunction in diabetes – the ‘forgotten’ diabetes complication: a narrative review
Published 2025-01-01Get full text
Article -
42
Sociodemographic and Lifestyle Factors in relation to Overweight Defined by BMI and “Normal-Weight Obesity”
Published 2020-01-01Get full text
Article -
43
-
44
-
45
Amino Acid Signatures to Evaluate the Beneficial Effects of Weight Loss
Published 2017-01-01Get full text
Article -
46
-
47
-
48
Haemodynamic Monitoring Using Echocardiography in the Critically Ill: A Review
Published 2012-01-01Get full text
Article -
49
An Unusual Presentation of Lupus Vulgaris and the Practical Usefulness of Dermatoscopy
Published 2018-01-01Get full text
Article -
50
Innovations in Lung Transplant Research and Practice: The Future is Now
Published 2025-02-01Get full text
Article -
51
Oxidative Stress and Its Biomarkers in Cardiovascular Diseases
Published 2024-10-01Get full text
Article -
52
A Case of Recurrent Erysipelas Caused by Streptococcus mitis Group
Published 2018-01-01Get full text
Article -
53
-
54
Whole genome sequencing in early onset advanced heart failure
Published 2025-02-01Get full text
Article -
55
-
56
-
57
Balancing inflammation: the specific roles of serum amyloid A proteins in sterile and infectious diseasese
Published 2025-02-01Get full text
Article -
58
The biting midge Forcipomyia paludis (Macfie, 1936) (Diptera: Ceratopogonidae) in Slovenia, Bosnia and Herzegovina, Croatia and Sweden
Published 2017-06-01“…In Croatia, the species is present in several parts of the country, while in Sweden it occurs only in the southern and middle parts of the country (Skåne, Öland, Gotland, Göteborg and Gävle). Six new dragonfly host species and the northernmost occurrence of F. paludis are also reported. …”
Get full text
Article -
59
-
60
Antisecretory factor in severe traumatic brain injury (AFISTBI): protocol for an exploratory randomized placebo-controlled trial
Published 2025-02-01“…Methods/design This is a single-center, randomized, placebo-controlled clinical phase 2 trial, investigating the clinical superiority of Salovum® given as a food supplement during 5 days to adults with severe TBI (Glasgow Coma Scale (GCS) < 9), admitted to the neurocritical intensive care unit (NICU) at Skane university hospital, Lund, Sweden. All patients with GCS < 9 and clinical indication for insertion of ICP-monitor and microdialysis catheter will be screened for inclusion and assigned to either the treatment group (n = 10) or placebo group (n = 10). …”
Get full text
Article